Adagio Therapeutics Announces Expansion of Management Team and Board of Directors to Support ...

WALTHAM, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases

Related Keywords

New York ,United States ,Johns Hopkins University ,Maryland ,Johns Hopkins Hospital ,New Jersey ,Baltimore ,Ellen Marram ,Dan Budwick ,Monique Allaire ,Davis Polk Wardwell ,Eli Lilly ,Tillman Gerngross ,Jill Andersen ,Rene Russo ,Johns Hopkins ,Redonda Miller ,Adagio Therapeutics Inc ,Ohio State University ,Nasdaq ,Novartis ,Johns Hopkins Carey Business School ,National Academy Of Medicine ,Maryland Chamber ,Nabisco Biscuit Company ,Novartis Consumer Health ,Ford Motor Company ,Novartis Services ,School Of Law ,Bristol Myers Squibb ,Department Of Medicine ,Boston College ,Wake Forest University ,Johns Hopkins Health System ,Wellesley College ,Johns Hopkins University School Of Medicine ,Tropicana Beverage Group ,Harvard Business School ,Strategic Communications ,New York Times ,Newman Own Inc ,Novartis Pharmaceuticals Corporation ,Newman Own Foundation ,Oyster Point Pharma ,Davis Polk ,World Report Honor Roll ,Johns Hopkins Health ,National Academy ,Commerce Business Hall ,Johns Hopkins University School ,Ohio State ,Motown Inc ,Adagio Therapeutics ,Looking Statements This ,Private Securities Litigation Reform Act ,Quarterly Report ,Money ,Ational ,